Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Vincristine in Pediatric and Adolescent Relapsed Malignancies
NCT00038207Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2000
- Primary completion
- Sep 2004
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of vincristine sulfate liposome in soft tissue sarcoma (STS), lymphoma, leukemia, Wilms' tumor, osteosarcoma (OS), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2000; status: completed.
02
Drugs
vincristine sulfate liposome
03
Conditions
soft tissue sarcoma (STS)lymphomaleukemiaWilms' tumorosteosarcoma (OS)
Beyond the preview
Go deeper on NCT00038207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038207.